Takeda and ImmunoGen partner to develop and commercialise Elahere in Japan
ImmunoGen is expected to receive an upfront payment from Takeda plus additional payment
Read More
Tag: ImmunoGen
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
